Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
Launched by SHANGHAI MENTAL HEALTH CENTER · Mar 25, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying new ways to help patients with severe mental disorders, such as schizophrenia, bipolar disorder, and others, improve their mental health and daily lives. The goal is to use advanced technology and artificial intelligence to better understand how patients are doing and to tailor rehabilitation programs to meet their individual needs. By combining different types of data and learning methods, the researchers hope to create a more effective and personalized approach to mental health rehabilitation, which could help patients regain their social functions and integrate back into society.
To participate in the trial, individuals must be between 18 and 65 years old, have a diagnosis of one of the specified severe mental disorders, and be registered in the Shanghai Mental Health Information Management System. They also need to have normal vision and hearing or be correctable to normal. Participants will undergo rehabilitation training and be monitored closely throughout the process to evaluate how well the treatments are working. This study is currently recruiting and aims to use innovative methods to enhance the recovery journey for those affected by serious mental health issues.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Registered in the Shanghai Mental Health Information Management System,
- • Diagnosed patients with one of the six severe mental disorders: schizophrenia, schizoaffective disorder, paranoid psychosis, bipolar (affective) disorder, mental disorder due to epilepsy, and mental retardation accompanied by mental disorder,
- • Aged between 18 and 65 years old, ④ Normal vision or hearing, or within the normal range after correction, ⑤ Patients or their families have provided informed consent for this study and signed the informed consent form.
- Exclusion criteria:
- • Patients with severe physical illnesses or organic brain diseases.
About Shanghai Mental Health Center
Shanghai Mental Health Center is a leading institution dedicated to advancing mental health research and treatment. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and evidence-based practices to address a wide range of psychiatric disorders. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to enhancing patient care through rigorous clinical trials that contribute to the understanding and management of mental health conditions. Its mission is to foster collaboration among researchers, clinicians, and patients to promote mental well-being and improve outcomes in mental health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Jun Cai
Principal Investigator
Shanghai Mental Health Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported